These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 871863)

  • 1. Acetylator phenotype in diabetic neuropathy.
    McLaren EH; Burden AC; Moorhead PJ
    Br Med J; 1977 Jul; 2(6082):291-3. PubMed ID: 871863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dimorphism according to acetylator status.
    Burrows AW; Hockaday TD; Mann JI; Taylor JG
    Br Med J; 1978 Jan; 1(6107):208-10. PubMed ID: 340001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotypes in diabetes mellitus.
    Stryjek-Kamińska D; Malczewski B; Kopeć A; Rowińska-Marcińska K
    Acta Diabetol Lat; 1988; 25(1):41-8. PubMed ID: 3407376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator status and diabetic neuropathy.
    Shenfield GM; McCann VJ; Tjokresetio R
    Diabetologia; 1982 Jun; 22(6):441-4. PubMed ID: 7106444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between acetylator phenotype and neuropathy in diabetes mellitus patients.
    Surana MK; Mathur AK; Banerjee K; Agarwal TD
    J Assoc Physicians India; 1982 Jul; 30(7):437-9. PubMed ID: 7169467
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic and metabolic studies in diabetic neuropathy.
    Boulton AJ; Worth RC; Drury J; Hardisty CA; Wolf E; Cudworth AG; Ward JD
    Diabetologia; 1984 Jan; 26(1):15-9. PubMed ID: 6706042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glucose on acetylation status.
    Suhardjono D; Boutagy J; Shenfield GM
    Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
    Gawrońska-Szklarz B; Górnik W; Pawlik A; Kunicki P; Wójcicki J; Sitkiewicz D; Sych Z
    Eur J Clin Pharmacol; 1997; 51(6):431-5. PubMed ID: 9112055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylation in healthy and diseased children.
    Hadasová E; Brysová V; Kadlcáková E
    Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylator phenotype and congenital malformations.
    Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
    Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic changes in peripheral nerves in patients with 2 acetylation types of diabetes mellitus].
    Kopeć A; Rowińska-Marcińska K; Stryjek-Kamińska D; Malczewski B
    Neurol Neurochir Pol; 1986; 20(6):547-52. PubMed ID: 3600972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC; Ladero JM; Fernández-Gundín MJ; Robledo A
    Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of the slow acetylator phenotype with bladder cancer.
    Evans DA; Eze LC; Whibley EJ
    J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic acetylator polymorphism in breast cancer patients.
    Ladero JM; Fernández MJ; Palmeiro R; Muñoz JJ; Jara C; Lázaro C; Pérez-Manga G
    Oncology; 1987; 44(6):341-4. PubMed ID: 3684174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
    Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
    Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.